Skip to content
DraconiticResearch
Search Sources API
189,273 studies31 sourcesUpdated 53 min ago
Peer-reviewedPublisher termsmBio

Adaptive landscape of the metallo-β-lactamase NDM-1 to emerging β-lactam-based therapies

  • Fernanda D. Romero1
  • Salvador I. Drusin2,3
  • Guillermo Bahr1,2
  • Gastón González1
  • Robert A. Bonomo4,5,6,7,8
  • Diego M. Moreno2,3
  • Lisandro J. González1,2
  • Alejandro J. Vila1,2
8 affiliations
  1. 1Instituto de Biología Molecular y Celular de Rosario (IBR), CONICET, Universidad Nacional de Rosario
  2. 2Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario
  3. 3Instituto de Química Rosario (IQUIR), CONICET, Universidad Nacional de Rosario
  4. 4Departments of Molecular Biology and Microbiology, Medicine, and Biochemistry, Case Western Reserve University School of Medicine
  5. 5CWRU-Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES)
  6. 6Research Service, Veterans Affairs Northeast Ohio Healthcare System
  7. 7Departments of Pharmacology and Proteomics and Bioinformatics, Case Western Reserve University School of Medicine
  8. 8Clinician Scientist Investigator, Veterans Affairs Northeast Ohio Healthcare System
Open at sourcePDFDOICite

Related

  1. Insight into the mechanism of molecular interactions of the NDM metallo-beta-lactamase and cyclic boronate inhibition by molecular docking and molecular dynamics simulations
    Y.-F. Shi
    bioRxivPreprintAll rights reservedFull textBioinformatics & computational biologybioRxiv
  2. Cryptic Genes as Building Blocks of Antimicrobial Resistance: Evidence from a Novel Marine Imipenem-Hydrolyzing Metallo-β-Lactamase
    P. Gupta, P. Yadav, J. Kishan +8
    bioRxivPreprintCC BY-NCFull textMicrobiologybioRxiv
  3. Metallo-β-lactamase mediated resistance and Class 1 integron in carbapenem-resistant Enterobacterales isolates from the clinical specimens of Nepal
    Manisha Shrestha, Suchitra Thapa, Basudha Shrestha +4
    BMC MicrobiologyPeer-reviewedCC BYFull textMicrobiologyDOAJ
  4. L-Histidine resensitizes multidrug-resistant bacteria to carbapenems by inhibiting New Delhi metallo-β-lactamase activity
    Yanqing Yin, Sulan Hu, Dan Fang +5
    PLOS PathogensPeer-reviewedCC BY 4.0Full textEnzymology & metabolismProteomics & metabolomicsPLOSPMC
  5. Clinical trial landscape and translational priorities for adoptive T-cell and NK-cell therapies in gynecologic malignancies
    Qingyu Chen, Yuxin Zhu, Shilin Ye +2
    Frontiers in immunologyPeer-reviewedCC BYFull textImmunologyEurope PMC

Cite

BibTeXRIS
BibTeX
@article{romero2026adaptive,
  title = {{Adaptive landscape of the metallo-β-lactamase NDM-1 to emerging β-lactam-based therapies}},
  author = {Fernanda D. Romero and Salvador I. Drusin and Guillermo Bahr and Gastón González and Robert A. Bonomo and Diego M. Moreno and Lisandro J. González and Alejandro J. Vila},
  journal = {mBio},
  year = {2026},
  month = oct,
  doi = {10.1128/mbio.02280-26},
  url = {https://journals.asm.org/doi/10.1128/mbio.02280-26},
}
RIS
TY  - JOUR
TI  - Adaptive landscape of the metallo-β-lactamase NDM-1 to emerging β-lactam-based therapies
AU  - Fernanda D. Romero
AU  - Salvador I. Drusin
AU  - Guillermo Bahr
AU  - Gastón González
AU  - Robert A. Bonomo
AU  - Diego M. Moreno
AU  - Lisandro J. González
AU  - Alejandro J. Vila
PY  - 2026
DA  - 2026/10/12
JO  - mBio
DO  - 10.1128/mbio.02280-26
UR  - https://journals.asm.org/doi/10.1128/mbio.02280-26
SN  - 2150-7511
ER  -